Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01965535
What this trial is testing

Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection

Who this might be right for
HCV Infection
Gilead Sciences 155
Post-approval studies (Phase 4)WithdrawnNCT02485080
What this trial is testing

Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1

Who this might be right for
PT-NANBH
Stanford University
Large-scale testing (Phase 3)Study completedNCT02219490
What this trial is testing

Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection Genotype 1
AbbVie 1,596
Post-approval studies (Phase 4)Study completedNCT01591460
What this trial is testing

A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 165
Testing effectiveness (Phase 2)Study completedNCT02243280
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 174
Early research (Phase 1)Study completedNCT00529321
What this trial is testing

Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C Virus

Who this might be right for
Hepatitis C, Chronic
Transgene 42
Testing effectiveness (Phase 2)Study completedNCT01221298
What this trial is testing

A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV)

Who this might be right for
Hepatitis CHCVChronic Hepatitis C Infection+1 more
AbbVie (prior sponsor, Abbott) 11
Large-scale testing (Phase 3)Study completedNCT03219216
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 100
Not applicableStudy completedNCT00926016
What this trial is testing

Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

Who this might be right for
Chronic Hepatitis C
Brooke Army Medical Center 23
Early research (Phase 1)Study completedNCT01247194
What this trial is testing

A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1

Who this might be right for
Chronic Genotype 1 Hepatitis C Virus Infection
Presidio Pharmaceuticals, Inc. 24
Large-scale testing (Phase 3)Study completedNCT01701401
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 870
Large-scale testing (Phase 3)Ended earlyNCT01467479
What this trial is testing

Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 185
Large-scale testing (Phase 3)Study completedNCT01289782
What this trial is testing

An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Patients

Who this might be right for
Hepatitis C
Janssen R&D Ireland 395
Testing effectiveness (Phase 2)Study completedNCT01054729
What this trial is testing

Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients

Who this might be right for
Hepatitis C
Gilead Sciences 64
Not applicableStudy completedNCT04189627
What this trial is testing

The Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 99
Not applicableStudy completedNCT02642640
What this trial is testing

Interaction of Melatonin and MTNR1B Genotype on Glucose Control - Study 1

Who this might be right for
GlucoseCircadian RhythmMelatonin+1 more
Brigham and Women's Hospital 23
Large-scale testing (Phase 3)Study completedNCT02600325
What this trial is testing

Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV

Who this might be right for
Acute Hepatitis CHuman Immunodeficiency VirusHepatitis C
Erasmus Medical Center 80
Early research (Phase 1)Looking for participantsNCT04361708
What this trial is testing

Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies

Who this might be right for
Pancreatic AdenocarcinomaGastroesophageal Junction AdenocarcinomaAdenocarcinoma
University of Chicago 54
Testing effectiveness (Phase 2)Ended earlyNCT01467505
What this trial is testing

An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 61
Large-scale testing (Phase 3)Study completedNCT01939197
What this trial is testing

A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 318
Next Page